Skip to main content
BrainCited

Curcumin per Age-Related Cognitive Decline

B

A UCLA 18-month RCT found bioavailable curcumin improved memory test performance and reduced brain amyloid/tau PET signals in non-demented adults. Bioavailability of the formulation is the key factor for effectiveness.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dcurcumin\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

In sintesi

A UCLA 18-month RCT found bioavailable curcumin improved memory test performance and reduced brain amyloid/tau PET signals in non-demented adults. Bioavailability of the formulation is the key factor for effectiveness.

Key Study Findings

Review
Neuropharmacology of synaptic plasticity: pathways to cognitive resilience in healthy aging.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: aging individuals with cognitive decline

Review
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.
Dose: Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d vs: None Outcome: Cognitive decline in AD Effetto: None None

Popolazione: Alzheimer's disease patients

Review
Plant-based strategies against aging: Focus on bioactive compounds from medicine-food homology plants.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: None

Systematic Review
Curcumin and Dementia: A Systematic Review of Its Effects on Oxidative Stress and Cognitive Outcomes …
Dose: None vs: Various dementia models Outcome: Oxidative stress, inflammation, cognitive outcomes Effetto: MDA reduced 100%; cognition improved ~80% None

Popolazione: Rodent dementia models (29 studies)

Key Statistics

10

Studi

800

Partecipanti

Mixed

B

Grado

Referenced Papers

Molecules (Basel, Switzerland) 2025 16 citazioni
Behavioral neuroscience 2022 2 citazioni
Roczniki Panstwowego Zakladu … 2021 45 citazioni
Molecules (Basel, Switzerland) 2020 36 citazioni
International journal of … 2018 126 citazioni
Acta bio-medica : … 2018 103 citazioni
Advances in nutrition … 2017 215 citazioni
Molecular neurobiology 2010 145 citazioni
The Proceedings of … 2002 191 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
500-2,000 mg/day of enhanced bioavailability form
cognitivesupport:
90-180 mg/day Theracurmin or equivalent

Limite massimo: Well-tolerated up to 8,000 mg/day; 12,000 mg/day short-term

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Positive --
None -- Mixed --
None -- Mixed --
Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d -- Mixed --
None -- Mixed --
None -- Positive --
100 mg/kg each 4 weeks Positive --
None -- Positive --

Momento migliore per l'assunzione: With meals containing fat and black pepper (piperine) for absorption

Safety & Side Effects

Effetti collaterali segnalati

  • Gastrointestinal discomfort (nausea, diarrhea)
  • Headache
  • Skin rash (rare)
  • Yellow staining of teeth with powder forms

Interazioni note

  • Anticoagulants (may increase bleeding risk)
  • Antidiabetic drugs (may enhance blood sugar lowering)
  • CYP450 substrates (may affect drug metabolism)
  • Iron supplements (curcumin may chelate iron)

Livello di assunzione massimo tollerabile: Well-tolerated up to 8,000 mg/day; 12,000 mg/day short-term

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Curcumin help with Age-Related Cognitive Decline?
Based on 10 studies with 800 participants, there is moderate evidence from clinical studies that Curcumin may support Age-Related Cognitive Decline management. Our evidence grade is B (Good Evidence).
How much Curcumin should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 500-2,000 mg/day of enhanced bioavailability form. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Curcumin?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea), Headache, Skin rash (rare), Yellow staining of teeth with powder forms. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Curcumin and Age-Related Cognitive Decline?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 800 total participants. The overall direction of effect is mixed.

Related Evidence

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.